Momelotinib vs. ruxolitinib in myelofibrosis patients with thrombocytopenia
Jean-Jacques Kiladjian • 11 Dec 2020
What can be learnt about using interferon in patients with myelofibrosis?
Long-term 5-year data continues to show RESPONSE to ruxolitinib in polycythemia vera
Jean-Jacques Kiladjian • 3 Dec 2018
KRT‑232: first-in-class MDM2I for myelofibrosis R/R to JAK inhibitor therapy
Haifa Kathrin Al-Ali